Pyxis Oncology shareholders approve 5.5M share increase in equity plan at special meeting

Pyxis Oncology, Inc.

Shareholders voted 23,234,250 to 12,829,636 to approve amendment to 2021 Equity and Incentive Plan adding 5,500,000 shares.
Proposal to adjourn if needed passed but was unnecessary; quorum of 36,189,305 shares present.
59,422,945 shares outstanding; special meeting held virtually on October 23, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.